Page last updated: 2024-11-06
2-eicosanol
Description
2-Eicosanol, also known as behenyl alcohol, is a long-chain fatty alcohol found in various natural sources, including beeswax and plant oils. It is a white, waxy solid at room temperature. 2-Eicosanol has been investigated for its potential applications in cosmetics, pharmaceuticals, and food industries. Its long hydrocarbon chain provides a unique combination of properties, such as emollient and skin-conditioning effects, making it a valuable ingredient in skin care products. 2-Eicosanol has also been studied for its potential anti-inflammatory and antioxidant properties, although further research is needed to fully understand its biological effects. The synthesis of 2-Eicosanol typically involves the reduction of the corresponding fatty acid, behenic acid, using various chemical reagents. Its importance lies in its potential to serve as a sustainable and biocompatible alternative to synthetic chemicals commonly used in various industrial applications.'
icosan-2-ol : A secondary fatty alcohol that is icosane substituted by a hydroxy group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 65142 |
| SCHEMBL ID | 1999166 |
| MeSH ID | M0135433 |
Synonyms (8)
| Synonym |
|---|
| icosan-2-ol |
| 2-eicosanol |
| 1-methyl-1-nonadecanol |
| 4340-76-5 |
| SCHEMBL1999166 |
| 2-icosanol # |
| RHEVFAMQJMWLFS-UHFFFAOYSA-N |
| DTXSID20963007 |
Roles (1)
| Role | Description |
|---|
| bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| icosanol | A fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of twenty carbon atoms. |
| secondary fatty alcohol | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.67 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.62 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |